MAD2 Interacts with DNA Repair Proteins and Negatively Regulates DNA Damage Repair

Journal of Molecular Biology

Volumn 381, Issue 1, 2008, Pages 24-34

  Fung, Maggie K L ^a   Han, Hui Ying ^a   Leung, Steve C L ^a   Cheung, Hiu Wing ^a   Cheung, Annie L M ^a   Wong, Yong Chuan ^a   Ling, Ming Tat ^a   Wang, Xianghong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

DNA damage; DNA repair; MAD2

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; DNA; DOUBLE STRANDED DNA; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; HISTONE H2AX; NUCLEOTIDE; PROTEIN MAD2; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ARTICLE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EMBRYO; EXCISION REPAIR; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 46649103822     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.05.080     Document Type: Article

References (43)

1. Rudner A.D., and Murray A.W. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 8 (1996) 773-780
2. Fang G., Yu H., and Kirschner M.W. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev. 12 (1998) 1871-1883
3. Kallio M., Weinstein J., Daum J.R., Burke D.J., and Gorbsky G.J. Mammalian p55CDC mediates association of the spindle checkpoint protein Mad2 with the cyclosome/anaphase-promoting complex, and is involved in regulating anaphase onset and late mitotic events. J. Cell Biol. 141 (1998) 1393-1406
4. Mikhailov A., Cole R.W., and Rieder C.L. DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr. Biol. 12 (2002) 1797-1806
5. Garber P.M., and Rine J. Overlapping roles of the spindle assembly and DNA damage checkpoints in the cell-cycle response to altered chromosomes in Saccharomyces cerevisiae. Genetics 161 (2002) 521-534
6. Nitta M., Kobayashi O., Honda S., Hirota T., Kuninaka S., Marumoto T., et al. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 23 (2004) 6548-6558
7. Cheung H.W., Jin D.Y., Ling M.T., Wong Y.C., Wang Q., Tsao S.W., and Wang X. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res. 65 (2005) 1450-1458
8. Du Y., Yin F., Liu C., Hu S., Wang J., Xie H., et al. Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Biochem. Biophys. Res. Commun. 345 (2006) 1092-1098
9. Fung M.K., Cheung H.W., Ling M.T., Cheung A.L., Wong Y.C., and Wang X. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells. Br. J. Cancer 95 (2006) 475-484
10. Murakumo Y., Roth T., Ishii H., Rasio D., Numata S., Croce C.M., and Fishel R. A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J. Biol. Chem. 275 (2000) 4391-4397
11. Cheung H.W., Chun A.C., Wang Q., Deng W., Hu L., Guan X.Y., et al. Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents. Cancer Res. 66 (2006) 4357-4367
12. Kennedy R.D., and D'Andrea A.D. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J. Clin. Oncol. 24 (2006) 3799-3808
13. Campbell M.S., Chan G.K., and Yen T.J. Mitotic checkpoint proteins HsMAD1 and HsMAD2 are associated with nuclear pore complexes in interphase. J. Cell Sci. 114 (2001) 953-963
14. Ryan K.J., and Wente S.R. The nuclear pore complex: a protein machine bridging the nucleus and cytoplasm. Curr. Opin. Cell Biol. 12 (2000) 361-371
15. Tembe V., and Henderson B.R. Protein trafficking in response to DNA damage. Cell Signal. 19 (2007) 1113-1120
16. Welsh C., Day R., McGurk C., Masters J.R., Wood R.D., and Koberle B. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J. Cancer. 110 (2004) 352-361
17. Koberle B., Masters J.R., Hartley J.A., and Wood R.D. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr. Biol. 9 (1999) 273-276
18. Bootsma D., and Hoeijmakers J.H. The genetic basis of xeroderma pigmentosum. Ann. Genet. 34 (1991) 143-150
19. Kartalou M., and Essigmann J.M. Mechanisms of resistance to cisplatin. Mutat. Res. 478 (2001) 23-43
20. Ferry K.V., Hamilton T.C., and Johnson S.W. Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. Biochem. Pharmacol. 60 (2000) 1305-1313
21. Selvakumaran M., Pisarcik D.A., Bao R., Yeung A.T., and Hamilton T.C. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res. 63 (2003) 1311-1316
22. Batty D.P., and Wood R.D. Damage recognition in nucleotide excision repair of DNA. Gene 241 (2000) 193-204
23. Tran E.J., and Wente S.R. Dynamic nuclear pore complexes: life on the edge. Cell 125 (2006) 1041-1053
24. Baynton K., Bresson-Roy A., and Fuchs R.P. Distinct roles for Rev1p and Rev7p during translesion synthesis in Saccharomyces cerevisiae. Mol. Microbiol. 34 (1999) 124-133
25. Park C.H., Mu D., Reardon J.T., and Sancar A. The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor. J. Biol. Chem. 270 (1995) 4896-4902
26. Nocentini S., Coin F., Saijo M., Tanaka K., and Egly J.M. DNA damage recognition by XPA protein promotes efficient recruitment of transcription factor II H. J. Biol. Chem. 272 (1997) 22991-22994
27. Cummings M., Higginbottom K., McGurk C.J., Wong O.G., Koberle B., Oliver R.T., and Masters J.R. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair. Biochem. Pharmacol. 72 (2006) 166-175
28. Aloyz R., Xu Z.Y., Bello V., Bergeron J., Han F.Y., Yan Y., et al. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Res. 62 (2002) 5457-5462
29. Baumann P., and West S.C. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem. Sci. 23 (1998) 247-251
30. Lowndes N.F., and Toh G.W. DNA repair: the importance of phosphorylating histone H2AX. Curr. Biol. 15 (2005) R99-R102
31. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., et al. Genomic instability in mice lacking histone H2AX. Science 296 (2002) 922-927
32. Satoh M.S., and Hanawalt P.C. Competent transcription initiation by RNA polymerase II in cell-free extracts from xeroderma pigmentosum groups B and D in an optimized RNA transcription assay. Biochim. Biophys. Acta 1354 (1997) 241-251
33. Weber C.A., Salazar E.P., Stewart S.A., and Thompson L.H. ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J. 9 (1990) 1437-1447
34. Takayama K., Salazar E.P., Broughton B.C., Lehmann A.R., Sarasin A., Thompson L.H., and Weber C.A. Defects in the DNA repair and transcription gene ERCC2(XPD) in trichothiodystrophy. Am. J. Hum. Genet. 58 (1996) 263-270
35. Vermeulen W., Bergmann E., Auriol J., Rademakers S., Frit P., Appeldoorn E., et al. Sublimiting concentration of TFIIH transcription/DNA repair factor causes TTD-a trichothiodystrophy disorder. Nat. Genet. 26 (2000) 307-313
36. Santagati F., Botta E., Stefanini M., and Pedrini A.M. Different dynamics in nuclear entry of subunits of the repair/transcription factor TFIIH. Nucleic Acids Res. 29 (2001) 1574-1581
37. Schultz P., Fribourg S., Poterszman A., Mallouh V., Moras D., and Egly J.M. Molecular structure of human TFIIH. Cell 102 (2000) 599-607
38. Chen J., Larochelle S., Li X., and Suter B. Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature 424 (2003) 228-232
39. Dip R., Camenisch U., and Naegeli H. Mechanisms of DNA damage recognition and strand discrimination in human nucleotide excision repair. DNA Repair (Amst.) 3 (2004) 1409-1423
40. Saijo M., Matsuda T., Kuraoka I., and Tanaka K. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH. Biochem. Biophys. Res. Commun. 321 (2004) 815-822
41. Koberle B., Roginskaya V., and Wood R.D. XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells. DNA Repair (Amst.) 5 (2006) 641-648
42. Riedl T., Hanaoka F., and Egly J.M. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J. 22 (2003) 5293-5303
43. Fung M.K., Cheung H.W., Wong H.L., Yuen H.F., Ling M.T., Chan K.W., et al. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour. Biochim. Biophys. Acta 1773 (2007) 821-832